[go: up one dir, main page]

CY1119697T1 - Μεθοδος παρασκευης ενωσεων α-γαλακτοζυλο κεραμιδιων - Google Patents

Μεθοδος παρασκευης ενωσεων α-γαλακτοζυλο κεραμιδιων

Info

Publication number
CY1119697T1
CY1119697T1 CY20171101324T CY171101324T CY1119697T1 CY 1119697 T1 CY1119697 T1 CY 1119697T1 CY 20171101324 T CY20171101324 T CY 20171101324T CY 171101324 T CY171101324 T CY 171101324T CY 1119697 T1 CY1119697 T1 CY 1119697T1
Authority
CY
Cyprus
Prior art keywords
milkzozyl
preparation
tile compounds
tile
compounds
Prior art date
Application number
CY20171101324T
Other languages
English (en)
Inventor
Vincent Serra
Original Assignee
Abivax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abivax filed Critical Abivax
Publication of CY1119697T1 publication Critical patent/CY1119697T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μια μέθοδο παρασκευής ενώσεων α-γαλακτοζυλο κεραμιδιών του τύπου (I) που περιλαμβάνει ένα στάδιο α) γλυκοζυλίωσης μιας ένωσης του τύπου (II) με μια ένωση του τύπου (III).
CY20171101324T 2012-10-30 2017-12-18 Μεθοδος παρασκευης ενωσεων α-γαλακτοζυλο κεραμιδιων CY1119697T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261720098P 2012-10-30 2012-10-30
EP12306355.4A EP2727929A1 (en) 2012-10-30 2012-10-30 Method of preparation of alpha galactosyl ceramides compounds
EP13783936.1A EP2920194B1 (en) 2012-10-30 2013-10-30 Method of preparation of alpha-galactosyl ceramides compounds
PCT/EP2013/072711 WO2014067995A1 (en) 2012-10-30 2013-10-30 METHOD OF PREPARATION OF α-GALACTOSYL CERAMIDES COMPOUNDS

Publications (1)

Publication Number Publication Date
CY1119697T1 true CY1119697T1 (el) 2018-04-04

Family

ID=47172560

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101324T CY1119697T1 (el) 2012-10-30 2017-12-18 Μεθοδος παρασκευης ενωσεων α-γαλακτοζυλο κεραμιδιων

Country Status (23)

Country Link
US (1) US10870671B2 (el)
EP (2) EP2727929A1 (el)
JP (1) JP6140830B2 (el)
CN (2) CN109503682B (el)
AR (1) AR093270A1 (el)
AU (1) AU2013340901B2 (el)
BR (1) BR112015009720B1 (el)
CA (1) CA2888391C (el)
CU (1) CU24311B1 (el)
CY (1) CY1119697T1 (el)
DK (1) DK2920194T3 (el)
ES (1) ES2655655T3 (el)
HR (1) HRP20171687T1 (el)
HU (1) HUE035530T2 (el)
IL (1) IL238515B (el)
LT (1) LT2920194T (el)
MX (1) MX363944B (el)
PL (1) PL2920194T3 (el)
PT (1) PT2920194T (el)
RU (1) RU2662156C2 (el)
SI (1) SI2920194T1 (el)
WO (1) WO2014067995A1 (el)
ZA (1) ZA201502844B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112368291A (zh) * 2018-06-15 2021-02-12 碳码股份公司 糖基化鞘氨醇碱及其生产
CN110479184B (zh) * 2019-08-05 2021-09-07 华侨大学 一种琼脂糖基乳化剂及其制备方法和应用
EP4301374A4 (en) 2021-03-01 2025-09-10 Deciduous Therapeutics Inc COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS
WO2024050020A1 (en) * 2022-08-31 2024-03-07 Deciduous Therapeutics, Inc. Invariant natural killer t-cell activators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758395A (fr) * 1969-11-03 1971-05-03 Upjohn Co Procede de conversion d'halogenures de cis-glucosyle peracyles et nouveaux composes en derivant
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
FR2711138B1 (fr) 1993-10-12 1995-11-24 Oreal Céramides, leur procédé de préparation et leurs applications en cosmétique et en dermopharmacie.
CN1405172A (zh) 2001-08-13 2003-03-26 青岛海洋大学 一种乳糖胺脂及其制备方法和应用
BRPI0617687A2 (pt) * 2005-10-25 2011-08-02 Ludwig Inst Cancer Res composto, método para proteger um indivìduo mamìfero contra, ou tratar, um vìrus, infecção microbiana, parasita, uma doença auto-imune, cáncer, alergia ou asma, e, composição farmacêutica
BRPI0710668A2 (pt) 2006-04-07 2011-08-16 Scripps Res Insittute alfa-galactosil ceramidas modificadas para marcar e estimular células t matadoras naturais
CN101012254A (zh) 2006-08-29 2007-08-08 中国海洋大学 一种α-半乳糖鞘糖脂的2’-OH衍生物及其制备方法
ES2654382T3 (es) * 2011-01-05 2018-02-13 National Taiwan University Método para la preparación de glucoesfingolípidos

Also Published As

Publication number Publication date
EP2920194A1 (en) 2015-09-23
BR112015009720B1 (pt) 2022-06-14
ZA201502844B (en) 2016-09-28
SI2920194T1 (en) 2018-02-28
CU20150042A7 (es) 2016-04-25
CN109503682B (zh) 2023-07-07
MX363944B (es) 2019-04-09
CU24311B1 (es) 2018-01-10
LT2920194T (lt) 2017-12-27
PT2920194T (pt) 2018-01-09
AU2013340901A1 (en) 2015-04-30
CA2888391C (en) 2020-07-28
EP2727929A1 (en) 2014-05-07
CN109503682A (zh) 2019-03-22
HRP20171687T1 (hr) 2017-12-15
JP2016500056A (ja) 2016-01-07
RU2662156C2 (ru) 2018-07-24
WO2014067995A1 (en) 2014-05-08
AU2013340901A2 (en) 2015-05-14
US10870671B2 (en) 2020-12-22
AU2013340901B2 (en) 2017-08-10
BR112015009720A2 (pt) 2017-07-04
MX2015005592A (es) 2016-06-02
HUE035530T2 (en) 2018-05-02
CA2888391A1 (en) 2014-05-08
CN104812769A (zh) 2015-07-29
AR093270A1 (es) 2015-05-27
PL2920194T3 (pl) 2018-03-30
IL238515A0 (en) 2015-06-30
DK2920194T3 (en) 2017-12-04
ES2655655T3 (es) 2018-02-21
JP6140830B2 (ja) 2017-05-31
US20150291646A1 (en) 2015-10-15
RU2015116422A (ru) 2016-11-20
EP2920194B1 (en) 2017-10-11
IL238515B (en) 2018-05-31

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
CR20140042A (es) Indazoles
EA201590321A1 (ru) Дейтерированный барицитиниб
UA113643C2 (xx) N-цикліламіди як нематоциди
CR20140510A (es) Nucleósidos de espirooxetano de uracilo
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
CR20150271A (es) Peptidos como agonistas de oxitocina
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
CR20130625A (es) Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
CR20140094A (es) Derivados de etinilo
DK2557606T3 (da) Luminescent solkoncentrator omfattende disubstituerede benzothiadiazolforbindelser
CY1119492T1 (el) Παραγωγα καρβαμικα/ουριας
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης
CY1119697T1 (el) Μεθοδος παρασκευης ενωσεων α-γαλακτοζυλο κεραμιδιων
CY1118945T1 (el) Μεθοδος και ενδιαμεσα για την παρασκευη πρεγκαμπαλινης
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
CR20150087A (es) Derivados de pirazol-carboxamida
BR112014019289A8 (pt) Métodos para a preparação do composto de prome-dicamento de piperazina inibidor da ligação do hiv
CR20140531A (es) Derivados de ariletinilo